TY  - RPRT
TI  - Nanoparticle-delivered palbociclib enable CDK4/6 inhibitor therapy while combination with mTORC1 inhibitor sapanisertib induces long term benefits in SHH medulloblastoma.
AU  - Lim, C.
AU  - Dismuke, T.
AU  - Malawsky, D.
AU  - Ramsey, J. D.
AU  - Hwang, D.
AU  - Godfrey, V. L.
AU  - Kabanov, A. V.
AU  - Gershon, T. R.
AU  - Sokolsky, M.
PY  - 2021
DO  - 10.1101/2021.06.09.447757
UR  - https://www.biorxiv.org/content/10.1101/2021.06.09.447757v1
ID  - 10.1101/2021.06.09.447757
ER  -